Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 57, Issue 3, Pages 333-346
Publisher
Wiley
Online
2017-10-27
DOI
10.1002/mc.22758
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
- (2017) Fei Ma et al. MEDICINE
- Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
- (2016) Kumiko Kida et al. BREAST CANCER RESEARCH AND TREATMENT
- Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer
- (2016) Fuquan Zhang et al. CANCER SCIENCE
- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
- (2016) José Alexandre Ferreira et al. DRUG RESISTANCE UPDATES
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells
- (2015) Emanuele-Salvatore Scarpa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer
- (2015) S.S. Islam et al. MOLECULAR CARCINOGENESIS
- Triple negative breast cancer: looking for the missing link between biology and treatments
- (2015) Giuseppe Palma et al. Oncotarget
- Cisplatin Induces Bmi-1 and Enhances the Stem Cell Fraction in Head and Neck Cancer
- (2015) Carolina Nör et al. NEOPLASIA
- The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
- (2014) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways
- (2014) Vishwa Deepak et al. CONNECTIVE TISSUE RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model
- (2014) B Yin et al. ONCOGENE
- Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
- (2013) Ibtehaj Al-Sharif et al. BMC CANCER
- Differential marker expression by cultures rich in mesenchymal stem cells
- (2013) Andrew Wetzig et al. BMC CELL BIOLOGY
- ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
- (2013) E. Charafe-Jauffret et al. CANCER RESEARCH
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Interleukin-8 in Breast Cancer Progression
- (2013) Nataša Todorović-Raković et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Cytokines driving breast cancer stemness
- (2013) Andrew R. Chin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype
- (2013) Mizuki Yamamoto et al. Nature Communications
- Cisplatin Induces Differentiation of Breast Cancer Cells
- (2013) Praseetha Prabhakaran et al. Frontiers in Oncology
- Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
- (2013) P. Godwin et al. Frontiers in Oncology
- Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
- (2012) Yi Zhang et al. CANCER LETTERS
- Antiproliferative and Molecular Mechanism of Eugenol-Induced Apoptosis in Cancer Cells
- (2012) Saravana Kumar Jaganathan et al. MOLECULES
- Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line
- (2012) Shanmugam Hemaiswarya et al. PHYTOMEDICINE
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
- (2011) Alysha K. Croker et al. BREAST CANCER RESEARCH AND TREATMENT
- Eugenol Enhances the Chemotherapeutic Potential of Gemcitabine and Induces Anticarcinogenic and Anti-inflammatory Activity in Human Cervical Cancer Cells
- (2011) Arif Hussain et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Enhanced Anticancer Effect of the Combination of Cisplatin and TRAIL in Triple-Negative Breast Tumor Cells
- (2011) L. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
- (2011) D. Iliopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Y-Box Binding Protein-1 Induces the Expression ofCD44andCD49fLeading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
- (2010) Karen To et al. CANCER RESEARCH
- The Canonical NF- B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
- (2010) M. Liu et al. CANCER RESEARCH
- Inflammatory signaling pathways in self-renewing breast cancer stem cells
- (2010) Kunihiko Hinohara et al. CURRENT OPINION IN PHARMACOLOGY
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines
- (2009) Noritaka Yamaguchi et al. CANCER SCIENCE
- Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG
- (2009) P. Manikandan et al. INVESTIGATIONAL NEW DRUGS
- Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors
- (2008) N. Shafee et al. CANCER RESEARCH
- ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
- (2008) Julie Douville et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now